NUDCD3 deficiency disrupts V(D)J recombination to cause SCID and Omenn syndrome
Rui Chen,Elena Lukianova,Ina Schim van der Loeff,Jarmila Stremenova Spegarova,Joseph D.P. Willet,Kieran D. James,Edward J. Ryder,Helen Griffin,Hanna IJspeert,Akshada Gajbhiye,Frederic Lamoliatte,Jose L. Marin-Rubio,Lisa Woodbine,Henrique Lemos,David J. Swan,Valeria Pintar,Kamal Sayes,Elias R. Ruiz-Morales,Simon Eastham,David Dixon,Martin Prete,Elena Prigmore,Penny Jeggo,Joan Boyes,Andrew Mellor,Lei Huang,Mirjam van der Burg,Karin R. Engelhardt,Asbjørg Stray-Pedersen,Hans Christian Erichsen,Andrew R. Gennery,Matthias Trost,David J. Adams,Graham Anderson,Anna Lorenc,Gosia Trynka,Sophie Hambleton
DOI: https://doi.org/10.1126/sciimmunol.ade5705
IF: 30.63
2024-05-26
Science Immunology
Abstract:Inborn errors of T cell development present a pediatric emergency in which timely curative therapy is informed by molecular diagnosis. In 11 affected patients across four consanguineous kindreds, we detected homozygosity for a single deleterious missense variant in the gene NudC domain–containing 3 ( NUDCD3 ) . Two infants had severe combined immunodeficiency with the complete absence of T and B cells (T - B - SCID), whereas nine showed classical features of Omenn syndrome (OS). Restricted antigen receptor gene usage by residual T lymphocytes suggested impaired V(D)J recombination. Patient cells showed reduced expression of NUDCD3 protein and diminished ability to support RAG-mediated recombination in vitro, which was associated with pathologic sequestration of RAG1 in the nucleoli. Although impaired V(D)J recombination in a mouse model bearing the homologous variant led to milder immunologic abnormalities, NUDCD3 is absolutely required for healthy T and B cell development in humans.
immunology